Gland Pharma Limited
NSE: GLAND | Information Technology
Market Fundamentals
Stock Intelligence & News
Gland Pharma to Biocon: Pharma stocks rally up to 27% in a month: Can they shield portfolio from US-Iran war-led risks?
The Nifty Pharma index has surged nearly 11% over the past month, significantly outperforming the Nifty 50, which declined 3.6% during the same period. On a year-to-date (YTD) basis, the Nifty Pharma index has gained 9.4%, while the benchmark Nifty 50 has fallen by an equal margin.
Read Full Analysis →Cenexi recovery, new product launches and capacity additions power Gland Pharma outlook
Gland Pharma stock surged to a 52-week high following robust March quarter and full-year results. Its European unit, Cenexi, is improving profitability. Future growth is anticipated from capacity expansions and new product lines. The company's contract development and manufacturing business is also expanding. Investors are watching Gland Pharma's growth prospects.
Read Full Analysis →Bank of England gets time to assess Iran war impact, Bailey says
Bank of England gets time to assess Iran war impact, Bailey says
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Gland Pharma Limited
Gland Pharma Limited has informed the Exchange about Transcript |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →April CPI undershoots Bank of England expectations
Figures were encouraging, but with plenty of temporary effects, caution is warranted
Read Full Analysis →Immortalized Silk Gland Cell Line Breakthrough Expands Kraig Biocraft’s Biotech Ambitions (KBLB)
Immortalized Silk Gland Cell Line Breakthrough Expands Kraig Biocraft’s Biotech Ambitions (KBLB)
Read Full Analysis →The Bank of England’s oil shock modelling has gone awry
Assumptions used by the bank in August 2025 make no sense when applied to its April 2026 data
Read Full Analysis →Gland Pharma,6 stocks hit 52-week highs, rally up to 20% in a month
Gland Pharma,6 stocks hit 52-week highs, rally up to 20% in a month
Read Full Analysis →Top Gainers & Losers on May 18: Gland Pharma, Coforge, PB Fintech, BSE, Voltas, Bharti Airtel among top gainers
Indian stocks marginally gained on May 18, driven by strong tech buying and pharma support, with Nifty 50 up 0.03% at 23,649 and BSE Sensex at 75,263. However, the broader market faced pressure as Nifty Midcap 100 and Nifty Smallcap 100 fell.
Read Full Analysis →Gland Pharma shares jump 11% as Q4 profit soars 97% YoY, co announces Rs 20/share final dividend
Shares of Gland Pharma rallied on Monday after the company reported a 97% YoY surge in Q4 profit and strong revenue growth, driven by its CDMO business. The board also announced a ₹20-per-share final dividend for FY26, boosting investor sentiment.
Read Full Analysis →Get instant alerts when GLAND breaks news
Join investors who track Gland Pharma Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for GLAND?
GLAND is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Gland Pharma Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding GLAND to your custom watchlist.